tafenoquine has been researched along with nitd 609 in 1 studies
| Studies (tafenoquine) | Trials (tafenoquine) | Recent Studies (post-2010) (tafenoquine) | Studies (nitd 609) | Trials (nitd 609) | Recent Studies (post-2010) (nitd 609) |
|---|---|---|---|---|---|
| 186 | 37 | 113 | 46 | 7 | 42 |
| Protein | Taxonomy | tafenoquine (IC50) | nitd 609 (IC50) |
|---|---|---|---|
| Adenosine receptor A3 | Homo sapiens (human) | 8.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
1 review(s) available for tafenoquine and nitd 609
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |